Large Kaiser Permanente study highlights health system’s ability to track important factors that can impact health outcomes
Kaiser Permanente study also finds length of lifetime reproductive cycle can affect risk
Women who begin menopause before age 46 or after 55 have an increased risk of developing type 2 diabetes, according to a study of more than 124,000 women enrolled in the Women’s Health Initiative
, a large national trial aimed at preventing disease in postmenopausal women.
PORTLAND, Ore., October 27, 2015—A pharmacy-led glycemic control program is linked to improved outcomes for surgical patients with diabetes and those who develop stress-induced hyperglycemia or high blood sugars as a result of surgery, according to a new Kaiser Permanente study published in the American Journal of Pharmacy Benefits.
People with serious mental illnesses already at higher risk for obesity; medications that control their symptoms often lead to additional weight gain.
A recent study conducted by the Kaiser Permanente Center for Health Research shows that testing high-risk women for gestational diabetes in the first trimester of pregnancy may identify the worst cases of the condition, allowing for earlier treatment.
Researchers Use Database of More Than One Million Diverse Diabetes Patients to Find Better Treatment & Prevention Strategies
Patients with diabetes may be able to reduce their risk of heart attack and stroke by increasing their level of high-density lipoproteins (HDL), also known as the “good” cholesterol.
The sooner people with diabetes start taking metformin, the longer the drug remains effective, according to a Kaiser Permanente study published in the March issue of Diabetes Care, a journal of the American Diabetes Association.
Kaiser Permanente study first to measure gestational diabetes risk among 14 ethnic groups in Hawaii
CHR study on atrial fibrillation advances research in women’s cardiovascular health